Boston Scientific Corp (BSX)vsOwlet Inc (OWLT)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
OWLT
Owlet Inc
$5.11
-2.48%
HEALTHCARE · Cap: $150.38M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 18890% more annual revenue ($20.07B vs $105.71M). BSX leads profitability with a 14.4% profit margin vs -37.5%. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
OWLT
Avoid32
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Intrinsic value data unavailable for OWLT.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Revenue surging 29.6% year-over-year
Areas to Watch
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -8.0% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : OWLT
The strongest argument for OWLT centers on Revenue Growth. Revenue growth of 29.6% demonstrates continued momentum.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : OWLT
The primary concerns for OWLT are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
OWLT carries more volatility with a beta of 1.74 — expect wider price swings.
OWLT is growing revenue faster at 29.6% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BSX scores higher overall (63/100 vs 32/100) and 15.9% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Owlet Inc
HEALTHCARE · MEDICAL DEVICES · USA
Owlet Inc. is a pioneering leader in infant health technology, dedicated to improving the safety and well-being of newborns through innovative monitoring solutions. Its flagship product, the Owlet Smart Sock, utilizes advanced pulse oximetry to provide continuous tracking of infants' heart rates and oxygen levels, offering critical health insights directly to parents' mobile devices. As the demand for pediatric health monitoring continues to rise, Owlet is well-equipped to expand its product offerings and enhance its market position in the rapidly evolving infant health sector. By prioritizing actionable data for parents and advancing pediatric care, Owlet is establishing a significant presence at the convergence of healthcare and technology.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?